Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenka Kubiczkova

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Translational Medicine|September 5, 2012
TGF-β - an excellent servant but a bad masterLenka Kubiczkova, Lenka Sedlarikova, Roman Hajek, et al.
Leukemia Research|June 26, 2012
Mechanism of immunomodulatory drugs in multiple myelomaLenka Sedlarikova, Lenka Kubiczkova, Sabina Sevcikova, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 15, 2013
High-risk multiple myeloma: different definitions, different outcomes?Helena Paszekova, Fedor Kryukov, Lenka Kubiczkova, et al.
Journal of Cellular and Molecular Medicine|April 10, 2014
Proteasome inhibitors - molecular basis and current perspectives in multiple myelomaLenka Kubiczkova, Ludek Pour, Lenka Sedlarikova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 10, 2014
The miR-29 family in hematological malignanciesBarbora Fiserova, Lenka Kubiczkova, Lenka Sedlarikova, et al.
Leukemia & Lymphoma|June 21, 2012
Serum miR-29a as a marker of multiple myelomaSabina Sevcikova, Lenka Kubiczkova, Lenka Sedlarikova, et al.
International Journal of Colorectal Disease|April 6, 2012
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cellsPetra Faltejskova, Andrej Besse, Sabina Sevcikova, et al.
Plos One|November 16, 2012
Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairmentKarthick Raja Muthu Raja, Lenka Kubiczkova, Lucie Rihova, et al.
British Journal of Haematology|December 17, 2013
Nestin expression throughout multistep pathogenesis of multiple myelomaHana Svachova, Fedor Kryukov, Elena Kryukova, et al.
Leukemia & Lymphoma|January 18, 2013
Molecular heterogeneity and centrosome-associated genes in multiple myelomaFedor Kryukov, Pavel Nemec, Elena Dementyeva, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Translational Medicine|September 5, 2012
TGF-β - an excellent servant but a bad masterLenka Kubiczkova, Lenka Sedlarikova, Roman Hajek, et al.
Leukemia Research|June 26, 2012
Mechanism of immunomodulatory drugs in multiple myelomaLenka Sedlarikova, Lenka Kubiczkova, Sabina Sevcikova, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 15, 2013
High-risk multiple myeloma: different definitions, different outcomes?Helena Paszekova, Fedor Kryukov, Lenka Kubiczkova, et al.
Journal of Cellular and Molecular Medicine|April 10, 2014
Proteasome inhibitors - molecular basis and current perspectives in multiple myelomaLenka Kubiczkova, Ludek Pour, Lenka Sedlarikova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 10, 2014
The miR-29 family in hematological malignanciesBarbora Fiserova, Lenka Kubiczkova, Lenka Sedlarikova, et al.
Leukemia & Lymphoma|June 21, 2012
Serum miR-29a as a marker of multiple myelomaSabina Sevcikova, Lenka Kubiczkova, Lenka Sedlarikova, et al.
International Journal of Colorectal Disease|April 6, 2012
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cellsPetra Faltejskova, Andrej Besse, Sabina Sevcikova, et al.
Plos One|November 16, 2012
Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairmentKarthick Raja Muthu Raja, Lenka Kubiczkova, Lucie Rihova, et al.
British Journal of Haematology|December 17, 2013
Nestin expression throughout multistep pathogenesis of multiple myelomaHana Svachova, Fedor Kryukov, Elena Kryukova, et al.
Leukemia & Lymphoma|January 18, 2013
Molecular heterogeneity and centrosome-associated genes in multiple myelomaFedor Kryukov, Pavel Nemec, Elena Dementyeva, et al.
Pageof 2